Bohai Pharmaceuticals Group, Inc.: 10-Q filed 2013-02-14

Name: Bohai Pharmaceuticals Group, Inc.: 10-Q filed 2013-02-14
Creator: Bohai Pharmaceuticals Group, Inc.
License: https://creativecommons.org/licenses/by/4.0/

What Bohai Pharmaceuticals Group, Inc. reported in its quarterly report filed 2013-02-14 (fiscal Q2 2013): 46 published measures, 130 facts as tagged in accession 0001144204-13-008990.

This filing

Form: 10-Q (quarterly report)
Filed: 2013-02-14
Fiscal period: fiscal Q2 2013
Accession: 0001144204-13-008990 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All Bohai Pharmaceuticals Group, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2012-12-31	158,733,643	USD
At 2012-06-30	145,398,019	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2012-12-31	60,372,779	USD
At 2012-06-30	58,895,487	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2012-12-31	98,360,864	USD
At 2012-06-30	86,502,532	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2012-12-31	3,154,584	USD
At 2012-06-30	18,386,288	USD
At 2011-12-31	20,433,960	USD
At 2011-06-30	13,344,426	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	5,258,737	USD	92
2012-07-01 to 2012-12-31	11,654,249	USD	184
2011-10-01 to 2011-12-31	-1,295,502	USD	92
2011-07-01 to 2011-12-31	1,360,282	USD	184

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2012-07-01 to 2012-12-31	6,450,665	USD	184
2011-07-01 to 2011-12-31	11,690,444	USD	184

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2012-07-01 to 2012-12-31	433,131	USD	184
2011-07-01 to 2011-12-31	1,220,889	USD	184

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2012-07-01 to 2012-12-31	-1,563,480	USD	184
2011-07-01 to 2011-12-31	4,791,004	USD	184

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2012-07-01 to 2012-12-31	-20,226,648	USD	184
2011-07-01 to 2011-12-31	-9,604,548	USD	184

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2012-12-31	65,085,674	USD
At 2012-06-30	53,431,425	USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	17,861,085	shares	92
2012-07-01 to 2012-12-31	17,861,085	shares	184
2011-10-01 to 2011-12-31	17,861,085	shares	92
2011-07-01 to 2011-12-31	17,861,085	shares	184

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	22,093,335	shares	92
2012-07-01 to 2012-12-31	22,093,335	shares	184
2011-10-01 to 2011-12-31	17,861,085	shares	92
2011-07-01 to 2011-12-31	17,861,085	shares	184

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	0.29	USD/shares	92
2012-07-01 to 2012-12-31	0.65	USD/shares	184
2011-10-01 to 2011-12-31	-0.07	USD/shares	92
2011-07-01 to 2011-12-31	0.08	USD/shares	184

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	0.25	USD/shares	92
2012-07-01 to 2012-12-31	0.55	USD/shares	184
2011-10-01 to 2011-12-31	-0.07	USD/shares	92
2011-07-01 to 2011-12-31	0.08	USD/shares	184

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	1,758,578	USD	92
2012-07-01 to 2012-12-31	3,939,824	USD	184
2011-10-01 to 2011-12-31	2,296,292	USD	92
2011-07-01 to 2011-12-31	4,114,651	USD	184

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2012-12-31	11,840,729	USD
At 2012-06-30	11,681,272	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2012-07-01 to 2012-12-31	0	USD	184
2011-07-01 to 2011-12-31	44,000	USD	184

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	6,721,748	USD	92
2012-07-01 to 2012-12-31	15,312,458	USD	184
2011-10-01 to 2011-12-31	8,128,497	USD	92
2011-07-01 to 2011-12-31	14,878,144	USD	184

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2012-12-31	58,195,864	USD
At 2012-06-30	62,182,356	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	426,323	USD	92
2012-07-01 to 2012-12-31	939,356	USD	184
2011-10-01 to 2011-12-31	6,951,562	USD	92
2011-07-01 to 2011-12-31	9,574,073	USD	184

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2012-12-31	39,700,452	USD
At 2012-06-30	30,434,218	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2012-12-31	3,612,366	USD
At 2012-06-30	3,334,101	USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

Period	Value	Unit	Days
At 2012-12-31	5,096,740	USD
At 2012-06-30	5,092,139	USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

Period	Value	Unit	Days
At 2012-12-31	37,388,468	USD
At 2012-06-30	18,739,297	USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

Period	Value	Unit	Days
At 2012-12-31	42,866,521	USD
At 2012-06-30	29,670,552	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	25,578,497	USD	92
2012-07-01 to 2012-12-31	43,744,503	USD	184
2011-10-01 to 2011-12-31	18,725,992	USD	92
2011-07-01 to 2011-12-31	34,960,481	USD	184

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

Period	Value	Unit	Days
At 2012-12-31	3,280,053	USD
At 2012-06-30	3,795,915	USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	32,300,245	USD	92
2012-07-01 to 2012-12-31	59,056,961	USD	184
2011-10-01 to 2011-12-31	26,854,489	USD	92
2011-07-01 to 2011-12-31	49,838,625	USD	184

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	22,546,807	USD	92
2012-07-01 to 2012-12-31	39,753,923	USD	184
2011-10-01 to 2011-12-31	18,108,529	USD	92
2011-07-01 to 2011-12-31	33,713,420	USD	184

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2012-07-01 to 2012-12-31	0	USD	184
2011-07-01 to 2011-12-31	0	USD	184

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2012-12-31	17,861,085	shares
At 2012-06-30	17,861,085	shares

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

Period	Value	Unit	Days
At 2012-12-31	6,440,159	USD
At 2012-06-30	6,236,076	USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

Period	Value	Unit	Days
At 2012-12-31	12,321,938	USD
At 2012-06-30	11,913,458	USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

Period	Value	Unit	Days
At 2012-12-31	-2,477,830	USD
At 2012-06-30	-2,188,340	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2012-12-31	12,126,265	USD
At 2012-06-30	8,478,054	USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

Period	Value	Unit	Days
At 2012-12-31	487,141	USD
At 2012-06-30	879,696	USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	7,017,315	USD	92
2012-07-01 to 2012-12-31	15,594,073	USD	184
2011-10-01 to 2011-12-31	1,000,790	USD	92
2011-07-01 to 2011-12-31	5,474,933	USD	184

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	5,711,767	USD	92
2012-07-01 to 2012-12-31	11,858,332	USD	184
2011-10-01 to 2011-12-31	-254,522	USD	92
2011-07-01 to 2011-12-31	3,015,862	USD	184

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	5,258,737	USD	92
2012-07-01 to 2012-12-31	11,654,249	USD	184
2011-10-01 to 2011-12-31	-1,295,502	USD	92
2011-07-01 to 2011-12-31	1,360,282	USD	184

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	144,367	USD	92
2012-07-01 to 2012-12-31	287,490	USD	184
2011-10-01 to 2011-12-31	99,734	USD	92
2011-07-01 to 2011-12-31	236,391	USD	184

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	1,343,204	USD	92
2012-07-01 to 2012-12-31	2,302,094	USD	184
2011-10-01 to 2011-12-31	617,463	USD	92
2011-07-01 to 2011-12-31	1,247,061	USD	184

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	115	USD	92
2012-07-01 to 2012-12-31	-16,591	USD	184
2011-10-01 to 2011-12-31	-1,322	USD	92
2011-07-01 to 2011-12-31	-8,402	USD	184

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	295,567	USD	92
2012-07-01 to 2012-12-31	281,615	USD	184
2011-10-01 to 2011-12-31	-7,127,707	USD	92
2011-07-01 to 2011-12-31	-9,403,211	USD	184

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

Period	Value	Unit	Days
2012-07-01 to 2012-12-31	-323,476	USD	184
2011-07-01 to 2011-12-31	460,185	USD	184

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2012-07-01 to 2012-12-31	13,168,118	USD	184
2011-07-01 to 2011-12-31	3,034,163	USD	184

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

Period	Value	Unit	Days
2012-07-01 to 2012-12-31	-519,251	USD	184
2011-07-01 to 2011-12-31	99,530	USD	184

Inspect the source

Entity: Bohai Pharmaceuticals Group, Inc. / CIK 0001443242
Captured: 2026-09-22 19:49 UTC
SEC response SHA-256: 231cd66af3d2b49ce2aa3d470fecf13855af56710429934b8f03d791fb54b2d8

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001443242.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))